NTGN - Neon Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5140.52M
Enterprise Value 363.04M
Trailing P/E N/A
Forward P/E 1-1.82
PEG Ratio (5 yr expected) 1-0.07
Price/Sales (ttm)N/A
Price/Book (mrq)1.71
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.77

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.65%
Return on Equity (ttm)-109.73%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -81.98M
Net Income Avi to Common (ttm)-84.62M
Diluted EPS (ttm)-3.9490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)81.26M
Total Cash Per Share (mrq)2.87
Total Debt (mrq)8.6M
Total Debt/Equity (mrq)10.48
Current Ratio (mrq)7.30
Book Value Per Share (mrq)2.90

Cash Flow Statement

Operating Cash Flow (ttm)-69.65M
Levered Free Cash Flow (ttm)-44.6M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 34.08%
52 Week High 316.2300
52 Week Low 34.2000
50-Day Moving Average 35.3918
200-Day Moving Average 35.4979

Share Statistics

Avg Vol (3 month) 3141.81k
Avg Vol (10 day) 3103.85k
Shares Outstanding 528.33M
Float 15.5M
% Held by Insiders 117.19%
% Held by Institutions 170.35%
Shares Short (May 31, 2019) 4550.85k
Short Ratio (May 31, 2019) 45.68
Short % of Float (May 31, 2019) 43.80%
Short % of Shares Outstanding (May 31, 2019) 41.94%
Shares Short (prior month Apr 30, 2019) 4506.19k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A